Tildren

Tildren is a biphosphonate drug licensed for use in horses in Europe, but as yet unlicensed in the United States. In trials in Europe it has been shown to be effective in treating osteoarthritis in humans and horses. Tildren has the benefit of being a systemic therapy which can be used to treat multiple sites of osteoarthritis at once with a systemic administration, versus the standard individual intra-articular therapy. Dr. Revenaugh has been using Tildren successfully since 2002.